Alzheimer disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• APOE 16
• MAPT 2
• APP 1
• NRF2 0
• NLRP3 0
• TREM2 0
• AKT 0
• TDP-43 2
• BDNF 0
• PI3K 0
• BACE1 0
• GLP-1 1
• MAPK 0
• PPAR 0
• AMPK 0
• mTOR 0
• PSEN1 1
• STING 0
• ERK 0
• NMDA 1
• SNCA 0
• TLR4 0
• JNK 0
• SIRT1 0
• CTNNB1 0
• STAT3 0
• TP53 0
• TNF 0
• HDAC 0
• HIF-1 0
• SGLT2 0
• HMGB1 0
• GPX4 0
• IL-1 0
• PCSK9 0
• COX-2 0
• HSP90 1
• C9orf72 0
• DPP-4 0
• PINK1 0
• IL-17 0
• TFEB 0
• IL-6 0
• PD-L1 0
• VEGF 0
• YAP 0
• AQP4 0
• CD33 0
• IGF1R 0
• MMP-9 0
• CCR5 0
• EGFR 0
• FTO 0
• GBA1 0
• GIP 0
• JAK 0
• KEAP1 0
• PARP 0
• PD-1 0
• ACE2 0

EU-13 is a filter, not a ranking: it only narrows the list.

2 of 2+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

No trial in this view states that it shares participant data.

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 86
• Organoids 36
• Mendelian Randomization Analysis 136
• CRISPR-Cas Systems 24
• Gene Expression Profiling 175
• Sequence Analysis, RNA 20
• Whole Genome Sequencing 17
• Exome Sequencing 7
• Proteomics 228
• Metabolomics 81
• Mass Spectrometry 62
• Flow Cytometry 16
• Immunohistochemistry 74
• Liquid Biopsy 5
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 672
• Magnetic Resonance Imaging 992
• Machine Learning 253
• Deep Learning 166
• Cohort Studies 533
• Genome-Wide Association Study 215

• Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease.

  BMC Bioinformatics, Oct 2026

• A Lightweight EEG-Based Alzheimer's Disease Detection Framework on an Edge-Computing Platform Toward Future Intelligent Digital Twin Systems.

  J Integr Neurosci, Oct 2026

• Multi-Dimensional Feature Adaptive Gating Network for Multi-View and Whole-Brain Magnetic Resonance Imaging-Based Alzheimer's Disease Classification.

  J Vis Exp, Oct 2026

• Advances in artificial intelligence-driven MRI research in Alzheimer's disease.

  Front Neurol, Oct 2026

• The application progress of artificial intelligence in the diagnosis of Alzheimer's disease.

  Front Neurol, Oct 2026

• Deep learning-based prediction of regional brain Tau PET burden from MRI.

  Alzheimers Dement, Oct 2026

• Neuroimaging Biomarkers for Brain Disorder Diagnosis Using Advanced Learning Techniques.

  Int J Neural Syst, Sept 2026

• Learning age-conditioned brain atlases via free-prototype modeling for brain age prediction.

  Artif Intell Med, Sept 2026

• Predicting conversion from mild cognitive impairment to Alzheimer's disease: A systematic review of deep learning models for early-stage disease classification.

  Ageing Res Rev, Sept 2026

• SynthPET: A 3D generative AI approach for FDG-PET image synthesis from T1-weighted MRI and ASL CBF in Alzheimer's disease.

  Alzheimers Dement, Sept 2026

See which targets of this disease your abstract mentions, and go to the people working on them.